Works matching IS 00283835 AND DT 2024 AND VI 114 AND IP 9

Results: 12

Front & Back Matter.

Published in:: Neuroendocrinology, 2024, v. 114, n. 9, p. 798, doi. 10.1159/000541506
Publication type:: Article

Subject Index.

Published in:: Neuroendocrinology, 2024, v. 114, n. 9, p. 873, doi. 10.1159/000541091
Publication type:: Article

Author Index.

Published in:: Neuroendocrinology, 2024, v. 114, n. 9, p. 872, doi. 10.1159/000541090
Publication type:: Article

Prelims.

Published in:: Neuroendocrinology, 2024, v. 114, n. 9, p. 799, doi. 10.1159/000541089
Publication type:: Article

Radiation and Theranostics in Neuroendocrine Tumors: An Asian Perspective.

Published in:

2024

By:

Yan, Sean Xuexian

Publication type:

Editorial

Treatment and Long-Term Safety Outcomes of Peptide Receptor Radionuclide Therapy for Metastatic Neuroendocrine Tumours: An Asian Experience.

Published in:

Neuroendocrinology, 2024, v. 114, n. 9, p. 840, doi. 10.1159/000538523

By:

Tham, Wei Ying;
Huang, Hian Liang;
Tai, David Wai Meng;
Allen Jr., John C.;
Hwang, Jacqueline S.G.;
Loh, Lih Ming;
Goh, Brian K.P.;
Ong, Simon Y.K.;
Kek, Peng Chin;
Tan, Damien M.Y.;
Ng, David C.E.;
Loke, Kelvin S.H.

Publication type:

Article

Heterogeneity of Multiple Pancreatic Neuroendocrine Tumors Identified by 68Ga-DOTANOC and 68Ga-Exendin-4 PET/CT in a Patient with Endogenous Hyperinsulinemic Hypoglycemia and Multiple Endocrine Neoplasia 1.

Published in:

Neuroendocrinology, 2024, v. 114, n. 9, p. 866, doi. 10.1159/000538285

By:

Xu, Junyan;
Xu, Xiaoping;
Zhang, Meng;
Liu, Wensheng;
Chen, Jie;
Song, Shaoli

Publication type:

Article

A Review of the Evolving Role of Radiotherapy in the Treatment of Neuroendocrine Neoplasms.

Published in:

Neuroendocrinology, 2024, v. 114, n. 9, p. 856, doi. 10.1159/000538140

By:

Yit, Ling Fung Nelson;
Li, Youquan

Publication type:

Article

Circulating Regulatory T Cells: A Novel Marker Associated with Liver Metastasis and the Treatment Response of Transarterial Embolization in Gastroenteropancreatic Neuroendocrine Tumors.

Published in:

Neuroendocrinology, 2024, v. 114, n. 9, p. 827, doi. 10.1159/000535385

By:

Liu, Man;
Yu, Hang;
Chen, Luohai;
Yang, Dequan;
Liu, Haikuan;
Ouyang, Juan;
Zhang, Jiang;
Yan, Xu;
Luo, Yanji;
Lin, Yuan;
He, Qiao;
Chen, Minhu;
Zhang, Ning;
Wang, Yu

Publication type:

Article

Somatostatin Receptor Imaging in Mice with Difference Positive Rate of SSTR2.

Published in:

Neuroendocrinology, 2024, v. 114, n. 9, p. 848, doi. 10.1159/000535037

By:

Xie, Qing;
Zhou, Wenyuan;
Meng, Xiangxi;
Ding, Jin;
Li, Dan;
Lu, Ming;
Yang, Zhi;
Yu, Jiangyuan

Publication type:

Article

Predictive Factors of Early 18F-Fluorodeoxyglucose-Positron Emission Tomography Response to [131I] Metaiodobenzylguanidine Treatment for Unresectable or Metastatic Pheochromocytomas and Paragangliomas.

Published in:

Neuroendocrinology, 2024, v. 114, n. 9, p. 816, doi. 10.1159/000534175

By:

Takenaka, Junki;
Watanabe, Shiro;
Abe, Takashige;
Tsuchikawa, Takahiro;
Takeuchi, Satoshi;
Hirata, Kenji;
Kimura, Rina;
Wakabayashi, Naoto;
Shinohara, Nobuo;
Kudo, Kohsuke

Publication type:

Article

Prognostic Value of Somatostatin Receptor-Derived Volumetric Parameters from a Hybrid Standardized Uptake Value Thresholding Method in Patients with 68Ga-DOTATATE-Avid Stage IV Neuroendocrine Neoplasms: A Preliminary Study.

Published in:

Neuroendocrinology, 2024, v. 114, n. 9, p. 805, doi. 10.1159/000530771

By:

Cheng, Zhaoting;
Zou, Sijuan;
Zhou, Jianyuan;
Song, Shuang;
Zhu, Yuankai;
Zhao, Jun;
Zhu, Xiaohua

Publication type:

Article

Works matching IS 00283835 AND DT 2024 AND VI 114 AND IP 9

Front & Back Matter.

Subject Index.

Author Index.

Prelims.

Radiation and Theranostics in Neuroendocrine Tumors: An Asian Perspective.

Treatment and Long-Term Safety Outcomes of Peptide Receptor Radionuclide Therapy for Metastatic Neuroendocrine Tumours: An Asian Experience.

Heterogeneity of Multiple Pancreatic Neuroendocrine Tumors Identified by <sup>68</sup>Ga-DOTANOC and <sup>68</sup>Ga-Exendin-4 PET/CT in a Patient with Endogenous Hyperinsulinemic Hypoglycemia and Multiple Endocrine Neoplasia 1.

A Review of the Evolving Role of Radiotherapy in the Treatment of Neuroendocrine Neoplasms.

Circulating Regulatory T Cells: A Novel Marker Associated with Liver Metastasis and the Treatment Response of Transarterial Embolization in Gastroenteropancreatic Neuroendocrine Tumors.

Somatostatin Receptor Imaging in Mice with Difference Positive Rate of SSTR2.

Predictive Factors of Early <sup>18</sup>F-Fluorodeoxyglucose-Positron Emission Tomography Response to [<sup>131</sup>I] Metaiodobenzylguanidine Treatment for Unresectable or Metastatic Pheochromocytomas and Paragangliomas.

Prognostic Value of Somatostatin Receptor-Derived Volumetric Parameters from a Hybrid Standardized Uptake Value Thresholding Method in Patients with <sup>68</sup>Ga-DOTATATE-Avid Stage IV Neuroendocrine Neoplasms: A Preliminary Study.